Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial.
Authors: Spain RI; Department of VA, VA Portland Health Care System, OR.; Department of Neurology, Oregon Health & Science University, Portland, OR., Paz Soldán MM; Department of Veterans Affairs, VA Salt Lake City Health Care System, UT.; Department of Neurology, University of Utah, Salt Lake City., Freedman MS; Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, ON, Canada., Repovic P; Department of Neurology, Swedish Medical Center, Seattle, WA., Solomon AJ; Larner College of Medicine, University of Vermont, Burlington., Rinker JR; Department of Neurology, University of Alabama at Birmingham., Wallin MT; Department of Veterans Affairs, VA Washington DC Medical Center.; School of Medicine, University of Maryland, Baltimore, MD., Haselkorn JK; Department of Veterans Affairs, VA Puget Sound Health Care System, Seattle, WA.; Rehabilitation Medicine, University of Washington.; Department of Epidemiology, University of Washington, Seattle., Stuve O; Department of Veterans Affairs, North Texas Health Care System-Dallas.; Department of Neurology, University of Texas Southwestern Medical Center, Dallas.; Peter O'Donnell Brain Institute, University of Texas Southwestern Medical Center, Dallas., Gross RH; Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO., Waslo CS; Department of VA, VA Portland Health Care System, OR.; Department of Neurology, Oregon Health & Science University, Portland, OR., Hildebrand A; Biostatistics & Design Program, Oregon Health & Science University, Portland., Morris CD; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland; and., Mitchell J; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland; and., Turner AP; Department of Veterans Affairs, VA Puget Sound Health Care System, Seattle, WA.; Rehabilitation Medicine, University of Washington., Schwartz DL; Department of Neurology, Oregon Health & Science University, Portland, OR.; Advanced Imaging Research Center, Oregon Health & Science University, Portland., Metz J; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland; and., Rooney W; Advanced Imaging Research Center, Oregon Health & Science University, Portland.
Source: Neurology [Neurology] 2026 Jan 13; Vol. 106 (1), pp. e214454. Date of Electronic Publication: 2025 Dec 15.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1526-632X
DOI:10.1212/WNL.0000000000214454